Novellus Systems announced today that the company has developed new ceramic hard mask materials for use in sub-22nm patterning applications. Deposited using Novellus' industry-leading VECTOR plasma-enhanced chemical vapor deposition (PECVD) platform, the new materials allow for the controlled incorporation of dopants into the company's family of silicon carbide and silicon nitride films.
SEMATECH, a global consortium of chipmakers, announced today that Applied Seals North America, Inc., a leading provider of elastomeric sealing for the semiconductor, pharmaceutical, biotechnology and solar industries, has joined SEMATECH's Mask Blank Defect Reduction program at the College of Nanoscale Science and Engineering (CNSE) of the University at Albany.
Rapid, contactless and non-destructive testing of solar cells should lead to higher average solar cell efficiency and improved yield as manufacturers look to optimize production process and ramp up volume.
What is the size of a gambling die, zips around a microscope stage at 2mm/s but can stop on a dime with nanometer precision, then manipulate and probe anything from biological cells to semiconductors, MEMs or LEDs? They are the new "miBots" from Imina Technologies.
Nanometrics Incorporated, a leading supplier of advanced metrology systems, today introduced the Atlas II optical critical dimension system, a next-generation tool for high-performance process control metrology.
The new funding is intended for the further expansion of BioMers. This includes building a new production facility in Singapore, expanding the sales and marketing team and sales and marketing support activities focusing on Singapore, the US and selected countries in Europe.
A novel way of formulating a widely used class of pain medicines may allow reduced and more tolerable doses to be administered while preserving the pain-relieving effects of higher doses, according to multiple reports presented today at the annual meeting of the American College of Rheumatology (ACR).
New investors include GE, BioMed Ventures and Henri Termeer, former Chairman and CEO of Genzyme Corporation. All previous venture investors in NanoString also participated in the financing, including Clarus Ventures, Draper Fisher Jurvetson and OVP Venture Partners.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology, obesity, and regenerative medicine, today announced the publication of a white paper providing an overview of its proprietary dynamic polyconjugate (DPC) technology for safe and effective delivery of siRNA.
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology (ACR) in Chicago.
Mentor Graphics Corporation today announced the successful tapeout of a 20 nm test chip in collaboration with STMicroelectronics, marking a significant milestone in the development of a complete Mentor design-to-silicon solution for next-generation process technology.
NanoSmart Pharmaceuticals, Inc., a corporation developing novel cancer pharmaceuticals, has entered into a research collaboration with Children's Hospital Los Angeles, one of the nation's top pediatric hospitals, to develop and assess NanoSmart's novel drug-delivery platform.